AI-based drug developer Basecamp valued at $800 million after $140 million funding round

By Puyaan SinghBasecamp Research said on Wednesday it has raised $140 million in a Series C funding round that valued the AI-based drug developer at $800 million.The oversubscribed round was led by S32, with participation from Nvidia NASDAQ:NVDA, Anthropic's Anthology Fund, Catalio Capital Manageme…